L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release
NCT03534661
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Hyperlipidemias
Interventions
DRUG:
Teduglutide + Normal Saline
DRUG:
Teduglutide + L-NMMA
DRUG:
Placebo + L-NMMA
Sponsor
University Health Network, Toronto